Company Filing History:
Years Active: 2001-2006
Title: Innovations of Hua Chen in Glaucoma Research
Introduction
Hua Chen is an accomplished inventor based in San Francisco, CA (US). She has made significant contributions to the field of glaucoma research, holding a total of 3 patents. Her work focuses on the diagnosis, prognosis, and treatment of glaucoma and related disorders.
Latest Patents
Hua Chen's latest patents include innovative methods and kits for diagnosing and treating glaucoma. One notable invention involves the use of upstream sequences of the TIGR protein encoding sequence to assess sensitivity to steroids and the risk of glaucoma or ocular hypertensive disorders. The patents provide methods, kits, and nucleic acids that contain polymorphisms, base substitutions, or base additions located within the upstream region and within protein-encoding regions of the TIGR gene. These upstream sequences, including the TIGR promoter regions, can be utilized to generate cells, vectors, and nucleic acids that are useful in various diagnostic and prognostic methods, as well as therapeutic compounds and compositions.
Career Highlights
Hua Chen is affiliated with the University of California, where she continues her research and development in the field of glaucoma. Her work has garnered attention for its potential impact on improving diagnostic and treatment options for patients suffering from this condition.
Collaborations
Hua Chen collaborates with notable colleagues, including Thai D Nguyen and Jon R Polansky, to advance her research initiatives. Their combined expertise contributes to the innovative approaches being developed in the realm of glaucoma treatment.
Conclusion
Hua Chen's contributions to glaucoma research through her patents and collaborations highlight her role as a leading inventor in the field. Her work promises to enhance the understanding and management of glaucoma, ultimately benefiting patients worldwide.